Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q2 EBITDA Rises To SEK 134 Million

July 15 (Reuters) - Vitrolife AB  VITR.ST :
    * JUNE 2021: GOOD GROWTH AND ACQUISITION OF IGENOMIX
    * JUNE 2021: GOOD GROWTH AND ACQUISITION OF IGENOMIX
    * Q2 SALES AMOUNTED TO SEK 382 (209) MILLION, CORRESPONDING
TO AN
INCREASE OF 83 PERCENT IN SEK
    * Q2 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) AMOUNTED TO SEK 134 (40) MILLION, CORRESPONDING TO A
MARGIN OF 35 (19) PERCENT
    * Q2 NET INCOME AMOUNTED TO SEK 86 (12) MILLION, WHICH GAVE
EARNINGS PER SHARE OF SEK 0.79 (0.11).

Source text for Eikon:  ID:nWkr9Xqx 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Vitrolife AB

See all news